Showing results (51-60 of 409) with videos related to
Sort By:
Pageof 41
Molecular Therapy. Oncology|April 10, 2024
Advances in cell-based delivery of oncolytic viruses as therapy for lung cancerGiti Esmail Nia, Elahe Nikpayam, Molood Farrokhi, et al.Molecular Therapy. Oncology|April 10, 2024
A dual-luciferase bioluminescence system for the assessment of cellular therapiesAlejandro G Torres Chavez, Mary K McKenna, Kishore Balasubramanian, et al.Molecular Therapy. Oncology|April 10, 2024
Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancerAdviti Naik, Boucif Lattab, Hanan Qasem, et al.Molecular Therapy. Oncology|April 10, 2024
Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunityDongjiao Wang, Fei Zou, Yu Li, et al.Molecular Therapy. Oncology|September 4, 2024
Dynamic changes of the immune microenvironment in the development of gastric cancer caused by inflammationSiyuan Gan, Changfu Li, Rui Hou, et al.Molecular Therapy. Oncology|September 23, 2024
TYRP1 directed CAR T cells control tumor progression in preclinical melanoma modelsChristopher S Hackett, Daniel Hirschhorn, Meixian S Tang, et al.Molecular Therapy. Oncology|September 30, 2024
Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancerHeather K Lin, Dejah A Blake, Tongrui Liu, et al.Molecular Therapy. Oncology|October 15, 2024
APOBEC3B expression in 293T viral producer cells drives mutations in chimeric antigen receptors and reduces CAR T cell efficacyJack Swanson, Jason Tonne, Thanich Sangsuwannukul, et al.Molecular Therapy. Oncology|October 1, 2024
Genetic dysregulation of EP300 in cancers in light of cancer epigenome control - targeting of p300-proficient and -deficient cancersKarolina Gronkowska, Agnieszka RobaszkiewiczMolecular Therapy. Oncology|July 29, 2024
Comprehensive machine learning-based integration develops a novel prognostic model for glioblastomaQian Jiang, Xiawei Yang, Teng Deng, et al.Pageof 41